Adam Wanner

University of Leicester — United Kingdom

Medicine · Health Sciences

52h-index10.7kcitations389works1.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Asthma and respiratory diseases(154), Inhalation and Respiratory Drug Delivery(82), Chronic Obstructive Pulmonary Disease (COPD) Research(67), Respiratory and Cough-Related Research(56), Respiratory Support and Mechanisms(42)

Publications387 total

Genetic risk score informed re-evaluation of phenotype quality control to maximize power in epidemiological studies: application to lung function
International Journal for Population Data Science·2026Open Access
GENOME-WIDE AND PATHWAY-SPECIFIC POLYGENIC EFFECTS ON CORTICOSTEROID RESPONSE IN PATIENTS WITH SEVERE INFECTIONS
Open Respiratory Archives·2026Open Access
Does the airway circulation influence airflow obstruction in asthma?
BMJ Open Respiratory Research·2025Open Access
A comparative study of bronchodilator response: utilizing pre-bronchodilator versus predicted normal values
BMC Pulmonary Medicine·2024· 5 citedOpen Access
Different Responses of Human Endothelial Cells to E-cigarette Brands and Flavors
2023
Accuracy and Reproducibility of Plethysmographic Thoracic Gas Volume Measurements in Healthy Subjects
2023
Normalizing Spirometric Bronchodilator Responses
2023
Lower respiratory tract microbiome composition and community interactions in smokers
Access Microbiology·2023· 12 citedOpen Access
Lower respiratory tract microbiome composition and community interactions in smokers
2022Open Access
Lower respiratory tract microbiome composition and community interactions in smokers
2022· 2 citedOpen Access
Remembering Marvin Sackner
CHEST Journal·2021Open Access
Pediatric Asthma Attack and Home Paint Exposure
International Journal of Environmental Research and Public Health·2021· 13 citedOpen Access
Detection of alpha-1 antitrypsin deficiency: the past, present and future
Orphanet Journal of Rare Diseases·2020· 36 citedOpen Access
Towards New Therapeutic Solutions for Alpha-1 Antitrypsin Deficiency: Role of the Alpha-1 Foundation
Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation·2020· 3 citedOpen Access
Losartan Rescues Inflammation-related Mucociliary Dysfunction in Relevant Models of Cystic Fibrosis
American Journal of Respiratory and Critical Care Medicine·2019· 43 citedOpen Access
Pediatric Asthma Exacerbation and Home Paint Exposure
2019
Effect of Inhaled Albuterol on Pulmonary Vascular Resistance in Patients with Group 1 Pulmonary Arterial Hypertension on Oral Pulmonary Vasodilator Therapy: A Proof of Concept Study
2019
Inhaled liposomal ciprofloxacin in patients with non-cystic fibrosis bronchiectasis and chronic lung infection with Pseudomonas aeruginosa (ORBIT-3 and ORBIT-4): two phase 3, randomised controlled trials
The Lancet Respiratory Medicine·2019· 198 citedOpen Access
MZ carrier state in alpha-1 antitrypsin deficiency: Summary of the 16th Gordon L. Snider critical issues workshop, Bethesda, Maryland, November 13, 2017
Translational Science of Rare Diseases·2018Open Access
Why Publish Scientific Meeting Proceedings?
Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation·2018· 1 citedOpen Access
page 1 of 20Next →

Frequent Co-authors

William M. Abraham(11), Lora E. Fleming(7), Barbara Kirkpatrick(7), Lorraine C. Backer(7), Judy A. Bean(7), Daniel G. Baden(7), Yung Sung Cheng(6), Matthias Salathé(5), Andrew Reich(5), Jérôme Naar(5), Richard H. Pierce(5), Julia Zaias(4), Gregory E. Conner(4), Ignacio Danta(4), M Sielczak(4), Kate Nierenberg(3), Julie Hollenbeck(3), Gary J. Kirkpatrick(3), Robert Tamer(3), Gábor Horváth(3)